-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GhDdVslC/yGxUMTkNf9xHRSxknEAqT9WEwN1TC31tFS3KsM/NN3sLBGImGpjZifc 0mqapc7VqJKMAt6xbbxAyA== 0000904454-10-000452.txt : 20101122 0000904454-10-000452.hdr.sgml : 20101122 20101122211034 ACCESSION NUMBER: 0000904454-10-000452 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20101122 FILED AS OF DATE: 20101122 DATE AS OF CHANGE: 20101122 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DP VII ASSOCIATES LP CENTRAL INDEX KEY: 0001372932 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34962 FILM NUMBER: 101210104 BUSINESS ADDRESS: STREET 1: ONE PALMER SQ STREET 2: STE 515 CITY: PRINCETON STATE: NJ ZIP: 08542 MAIL ADDRESS: STREET 1: ONE PALMER SQ STREET 2: STE 515 CITY: PRINCETON STATE: NJ ZIP: 08542 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ZOGENIX, INC. CENTRAL INDEX KEY: 0001375151 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205300780 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12671 HIGH BLUFF DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 259-1165 MAIL ADDRESS: STREET 1: 12671 HIGH BLUFF DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: ZOGENIX INC DATE OF NAME CHANGE: 20060911 3 1 edgar.xml PRIMARY DOCUMENT X0203 3 2010-11-22 0 0001375151 ZOGENIX, INC. ZGNX 0001372932 DP VII ASSOCIATES LP C/O DOMAIN ASSOCIATES, LLC ONE PALMER SQUARE PRINCETON NJ 08542 0 0 1 0 Series A-1 Preferred Stock Common Stock 35215 D Series B Preferred Stock Common Stock 21027 D Convertible Promissory Notes Common Stock 14903 D Warrants 11.00 Series B Preferred Stock 2874 D All outstanding shares of the Issuer's preferred stock will automatically convert into Common Stock upon the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration. All Convertible Promissory Notes, plus interest accrued thereon, will automatically convert into Common Stock upon the closing of the IPO, at the IPO price. Assumes IPO price of $4.00 per share of Common Stock and IPO closing on or about November 29, 2010. Warrants are fully exercisable and will expire if not exercised in the IPO. If exercised upon closing of the IPO the Warrants will be net exercised, and therefore the number of shares of Common Stock issued to the Reporting Person will be adjusted in accordance with such net exercise. Share numbers reflect the 1-for-10 reverse split of the Common Stock effective immediately prior to the IPO. /s/ Kathleen K. Schoemaker, Managing Member of One Palmer Square Associates VII, LLC, General Partner of DP VII Associates, L.P. 2010-11-22 -----END PRIVACY-ENHANCED MESSAGE-----